Icon of the Instituts for Quality and Efficiency in Health Care

Report

Ezetimibe for hypercholesterolaemia

Status
Status: Commission completed
Project no.
A10-02
Last updated

Report documents

  1. Executive summary of the final report

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 55 kB, EN, not accessible
    Download file : Executive summary of the final report (PDF document, 55 kB, EN, not accessible)

  2. Final report

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 824 kB, DE, not accessible
    Download file : Final report (PDF document, 824 kB, DE, not accessible)

  3. Documentation and evaluation of comments on the preliminary report

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 648 kB, DE, not accessible
    Download file : Documentation and evaluation of comments on the preliminary report (PDF document, 648 kB, DE, not accessible)

  4. Executive summary of the preliminary report

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 33 kB, DE, not accessible
    Download file : Executive summary of the preliminary report (PDF document, 33 kB, DE, not accessible)

  5. Preliminary report

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 763 kB, DE, not accessible
    Download file : Preliminary report (PDF document, 763 kB, DE, not accessible)

  6. Report plan version 1.0

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 129 kB, DE, not accessible
    Download file : Report plan version 1.0 (PDF document, 129 kB, DE, not accessible)

  7. Documentation and appraisal of comments on the preliminary report plan

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 2 MB, not accessible
    Download file : Documentation and appraisal of comments on the preliminary report plan (PDF document, 2 MB, not accessible)

  8. Preliminary report plan

    Ezetimibe for hypercholesterolaemia

    published on
    Document type
    PDF document, 195 kB, DE, not accessible
    Download file : Preliminary report plan (PDF document, 195 kB, DE, not accessible)

Press releases

Elevated cholesterol levels: Benefit of ezetimibe is not proven

Prevention of heart attacks when statins are taken concomitantly remains unclear
Press release

Additional information

IQWiG health information

Coronary artery disease (CAD) develops if the blood vessels that supply the heart with oxygen become too narrow. These blood vessels are known as coronary arteries. The symptoms of CAD may differ, depending on how narrow the coronary arteries are and how long the person has had the disease. CAD is also called coronary heart disease (CHD).

Coronary artery disease

Project details

Project no.
A10-02
Commission
Commission awarded on 20.05.2010 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Heart and circulation

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page